A diverse landscape of FGFR alterations and co-mutations defines novel therapeutic strategies in pediatric low-grade gliomas
April Ann Apfelbaum, Eric Morin, Dominik Sturm, Georges Ayoub, Jeromy J. Digiacomo, Sher Bahadur, Bhavyaa Chandarana, Phoebe Power, Margaret M. Cusick, Dana Novikov, Prem Prabhakar, Robert E. Jones, Jayne R. Vogelzang, Connor C. Bossi, Seth W. Malinowski, , Pratiti Bandopadhayay
This study identifies FGFR alterations in pediatric gliomas, their association with specific histologies, and their response to targeted therapies.
Nature Communications · Jul 31, 2025Peer-reviewedCancer Biology